Further delineation of the NTHL1 associated syndrome: a report from the French oncogenetic consortium

被引：0

作者：

Boulouard, F. ^{[1
,2
,3
]}

Kasper, E. ^{[1
,2
]}

Buisine, M. ^{[4
]}

Lienard, G. ^{[1
,2
]}

Vasseur, S. ^{[1
,2
]}

Manase, S. ^{[1
,2
]}

Bahuau, M. ^{[5
]}

Bubien, V. ^{[6
]}

Coulet, F. ^{[7
]}

Cusin, V. ^{[8
]}

Dhooge, M. ^{[9
]}

Golmard, L. ^{[10
]}

Goussot, V. ^{[11
]}

Hamzaoui, N. ^{[12
]}

Lacaze, E.

Lejeune, S. ^{[13
]}

Mauillon, J. ^{[1
,2
]}

Pinson, S. ^{[14
]}

Tlemsani, C. ^{[15
]}

Toulas, C. ^{[16
]}

Rey, J. ^{[17
]}

Uhrhammer, N. ^{[18
]}

Bougeard-Denoyelle, G. ^{[1
,2
]}

Frebourg, T. ^{[1
,2
]}

Houdayer, C. ^{[1
,2
]}

Baert-Desurmont, S. ^{[1
,2
]}

机构：

[1] Normandie Univ, UNIROUEN, CHU Rouen, Ctr Normand Genom & Med Personnalisee,Dept Genet, Rouen, France

[2] Normandie Univ, UNIROUEN, CHU Rouen, Inserm,U1245, Rouen, France

[3] Ctr Francois Bacles, Lab Genet Mol, Caen, France

[4] Univ Lille, CHU Lille, INSERM, UMR S 1172,Inst Biochim & Biol Mol,Oncogenet Mol, Lille, France

[5] CHU Henri Mondor, Dept Biochim Biol Mol, Pharmacol, Genet Med, Creteil, France

[6] CLCC Inst Bergonie, Lab Genet Mol, Dept BioPathol, Unite Oncogenet, Bordeaux, France

[7] Charles Foix Hop Pitie Salpetriere, CHU Paris GH Pitie Salpetriere, UF Oncogenet & Angiogenet Mol, Dept Genet, Paris, France

[8] Charles Foix Hop Pitie Salpetriere, CHU Paris GH Pitie Salpetriere, Dept Genet, Paris, France

[9] Hop Cochin, CHU Paris Ctr, Serv Gastroenterol, Site Cochin, Paris, France

[10] PSL Res Univ, CLCC Inst Curie, Unite Genet Constitut, Serv Genet, Paris, France

[11] CLCC Georges Francois Leclerc, Dept Biol & Pathol Tumeurs, Dijon, France

[12] Hop Cochin, CHU Paris Ctr, Lab Oncogenet, Site Cochin, Paris, France

[13] Hop Jeanne de Flandre, CHU Lille, Pole Biol Pathol Genet, Clin Genet Guy Fontaine, Lille, France

[14] CHU Lyon HCL GH Est, Unite Med Genet Canc & Malad Multifactorielles, Serv Genet & Mol Clin, Lyon, France

[15] CHU Paris Ctr, Hop Cochin, Serv Cancerol, Site Cochin, Paris, France

[16] Inst Univ Canc Toulouse Oncopole, Lab Oncogenet, Toulouse, France

[17] CHU Montpellier, Hop Arnaud Villeneuve, Lab Biol Tumeurs Solides, Montpellier, France

[18] CLCC Jean Perrin, Lab Biol Med OncoGenAuvergne, Clermont Ferrand, France

来源：

EUROPEAN JOURNAL OF HUMAN GENETICS | 2020年 / 28卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

P12.168.B

引用

页码：543 / 543

页数：1

共 50 条

[1] Further delineation of the NTHL1 associated syndrome: A report from the French Oncogenetic Consortium
Boulouard, Flavie
Kasper, Edwige
Buisine, Marie-Pierre
Lienard, Gwendoline
Vasseur, Stephanie
Manase, Sandrine
Bahuau, Michel
Simonet, Emmanuelle Barouk
Bubien, Virginie
Coulet, Florence
Cusin, Veronica
Dhooge, Marion
Golmard, Lisa
Goussot, Vincent
Hamzaoui, Nadim
Lacaze, Elodie
Lejeune, Sophie
Mauillon, Jacques
Beaumont, Marie-Pascale
Pinson, Stephane
Tlemsani, Camille
Toulas, Christine
Rey, Jean-Marc
Uhrhammer, Nancy
Bougeard, Gaelle
Frebourg, Thierry
Houdayer, Claude
Baert-Desurmont, Stephanie
CLINICAL GENETICS, 2021, 99 (05) : 662 - 672
[2] NTHL1 defines novel cancer syndrome
Kuiper, Roland P.
Hoogerbrugge, Nicoline
ONCOTARGET, 2015, 6 (33) : 34069 - 34070
[3] A new family with a homozygous nonsense variant in NTHL1 further delineated the clinical phenotype of NTHL1-associated polyposis
Mays Altaraihi
Anne-Marie Gerdes
Karin Wadt
Human Genome Variation, 6
[4] A new family with a homozygous nonsense variant in NTHL1 further delineated the clinical phenotype of NTHL1-associated polyposis
Altaraihi, Mays
Gerdes, Anne-Marie
Wadt, Karin
HUMAN GENOME VARIATION, 2019, 6 (1)
[5] Benign Tumors Associated With Heterozygous NTHL1 Variant
Anderson, Danyon J.
Boyle, Andrew
Reinicke, Trenton
Woods, Bison
Hsieh, Patrick
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
[6] Colibactin mutational signatures in NTHL1 tumor syndrome and MUTYH associated polyposis patients
Terlouw, D.
Boot, A.
Ducarmon, Q. R.
Nooij, S.
Jessurun, M. A.
van Leerdam, M. E.
Tops, C. M.
Langers, A. M. J.
Morreau, H.
van Wezel, T.
Nielsen, M.
GENES CHROMOSOMES & CANCER, 2024, 63 (01):
[7] Extending the clinical phenotype associated with biallelic NTHL1 germline mutations
Fostira, Florentia
Kontopodis, Emmanouil
Apostolou, Paraskevi
Fragkaki, Maria
Androulakis, Nikolaos
Yannoukakos, Drakoulis
Konstantopoulou, Irene
Saloustros, Emmanouil
CLINICAL GENETICS, 2018, 94 (06) : 588 - 589
[8] Second Case of Tumors Associated With Heterozygous NTHL1 Variant
Anderson, Danyon J.
Reinicke, Trenton
Boyle, Andrew W.
Porwal, Mokshal H.
Friedman, Allan H.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)
[9] Two novel case reports of NTHL1 tumor syndrome support prior claims that NTHL1 is a multi-tumor predisposition gene
Weatherill, Chelsey
Darabi, Sourat
Homer, Jeanne
Demeure, Michael
MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S45 - S46
[10] NTHL1 associated head-neck carcinoma mimicking fanconi anaemia
Ahadli, F.
Grolleman, J.
Hartmann, B.
Lang, A.
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 102 - 102

← 1 2 3 4 5 →